Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Westaim Biomedical, Inc. — Predicate Candidate Screening

6 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

143 daysmedian FDA review time
342 days90th percentile
6clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K010447MODIFICATION TO ACTICOAT FOAM DRESSINGWestaim Biomedical, Inc.2001-03-15300
K002466ACTICOAT COMPOSITE DRESSINGWestaim Biomedical, Inc.2001-02-161890
K001519ACTICOAT 7 DRESSINGWestaim Biomedical, Inc.2000-10-061430
K992221ACTICOAT PRIMARY ANTIMICROBIAL DRESSINGWestaim Biomedical, Inc.2000-06-073420
K000051ACTICOAT FOAM DRESSINGWestaim Biomedical, Inc.2000-04-05891
K983833ACTICOAT COMPOSITE WOUND DRESSING, ACTICOAT COMPOSITE WOUND Westaim Biomedical, Inc.1998-12-10410

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda